Both dupilumab and mepolizumab were originally approved for asthma but were subsequently studied in patients with COPD who continue to experience symptoms and moderate-to-severe exacerbations despite ...
Inhaled maintenance therapy is underused among hospitalized patients with COPD in China, even in those with frequent prior hospitalizations.
A newly identified lung cell “switch” could help doctors unlock the lungs’ natural ability to heal themselves.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results